Sofwave Medical to Participate in Jefferies Private MedTech Virtual Summit

SAN CLEMENTE, Calif., Oct. 05, 2026 /CourierPR/ -- Sofwave Medical Ltd, an emerging leader in energy-based non-invasive aesthetic medical devices, will participate in the Jefferies Private MedTech Virtual Summit on October 7-8, 2026. The company’s CEO, Louis Scafuri, and Chief Financial Officer, Assaf Korner, will present on October 8 at 11:30 a.m. Eastern Time.

Sofwave Medical Ltd, listed on the Tel Aviv Stock Exchange under the ticker SOFW, is a global regenerative aesthetics company. Its proprietary SUPERB™ (Synchronous Ultrasound Parallel Beam) technology delivers controlled ultrasound energy to the mid-dermis, stimulating the body’s natural regenerative response. This technology is FDA-cleared for treating facial lines and wrinkles, lifting the eyebrow, lax submental and neck tissue, improving skin laxity on the upper arms, short-term improvement in the appearance of cellulite, and treating acne scars.

In addition to SUPERB™, Sofwave’s portfolio includes Pure Impact™, which uses electrical muscle stimulation (EMS) technology for muscle strengthening, toning, and firming. Together, these technologies provide physicians with clinically supported, non-invasive solutions for aesthetic patients worldwide.

The Jefferies Private MedTech Virtual Summit is expected to bring together key players in the private medical technology sector, offering a platform for discussions on the latest trends and innovations. Sofwave’s participation highlights the company’s commitment to staying at the forefront of non-invasive medical technology.

The presentation will provide a corporate overview, showcasing the company’s advancements and future plans. Interested parties can access the live webcast by clicking the provided link.

This participation in the Jefferies Private MedTech Virtual Summit underscores Sofwave’s dedication to expanding its reach and engaging with the broader medical technology community.